Vera Therapeutics, Inc.
VERA
$28.82
-$0.48-1.64%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 298.75% | 120.90% | 112.34% | 104.75% | 40.18% |
| Total Receivables | 636.91% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.63% | -21.14% | -2.72% | 63.84% | -17.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -59.19% | -41.26% | -69.34% | -35.67% | 211.13% |
| Total Current Assets | 278.56% | 112.17% | 107.09% | 103.65% | 36.85% |
|
|
|||||
| Total Current Assets | 278.56% | 112.17% | 107.09% | 103.65% | 36.85% |
| Net Property, Plant & Equipment | 42.45% | 22.02% | -48.80% | -45.83% | -41.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -72.82% | -70.21% | -1.08% | 3.05% | 5.93% |
| Total Assets | 273.51% | 109.86% | 103.55% | 100.07% | 33.56% |
|
|
|||||
| Total Accounts Payable | -31.06% | -62.59% | -64.88% | -2.20% | -7.28% |
| Total Accrued Expenses | 85.43% | 101.00% | 5.85% | -54.75% | -20.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -39.12% | -25.66% | -17.34% | -12.57% | -7.90% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.76% | 7.49% | -31.37% | -38.19% | -12.88% |
|
|
|||||
| Total Current Liabilities | 13.76% | 7.49% | -31.37% | -38.19% | -12.88% |
| Long-Term Debt | 1.62% | 101.54% | 101.36% | 101.18% | 101.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.92% | 30.89% | -82.30% | -71.23% | -63.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -0.35% | 0.00% | 0.00% |
| Total Liabilities | 6.32% | 53.15% | 27.02% | 26.82% | 35.46% |
|
|
|||||
| Common Stock & APIC | 152.84% | 73.33% | 73.14% | 72.41% | 41.45% |
| Retained Earnings | -49.22% | -47.41% | -40.95% | -38.78% | -45.04% |
| Treasury Stock & Other | 56.57% | 1,492.00% | -216.90% | -4,225.00% | 212.05% |
| Total Common Equity | 467.59% | 133.66% | 133.32% | 124.17% | 32.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 467.59% | 133.66% | 133.32% | 124.17% | 32.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 467.59% | 133.66% | 133.32% | 124.17% | 32.22% |
|
|
|||||
